Clinical Trials
3 trialsNCT01798056 2021-05-13
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Herpes Zoster (HZ/su) Vaccine in Adults With Solid Tumours Receiving Chemotherapy
GlaxoSmithKline
Phase 3 Completed
NCT01254630 2019-09-30
V212-011
Merck Sharp & Dohme LLC
Phase 3 Completed
NCT01460719 2019-03-11
V212-013
Merck Sharp & Dohme LLC
Phase 1 Completed